Dashboard
Manage Tickers

SGENSeagen Inc.

Nasdaq seagen.com


$ 228.86 $ -0.16 (-0.07 %)    

Wednesday, 13-Dec-2023 16:19:51 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 228.74
$ 228.93
$ 228.80 x 100
$ 0.00 x 0
$ 228.84 - $ 228.96
$ 123.77 - $ 228.96
20,075,430
na
43.03B
$ 0.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-01-2023 09-30-2023 10-Q
2 08-02-2023 06-30-2023 10-Q
3 04-27-2023 03-31-2023 10-Q
4 02-15-2023 12-31-2022 10-K
5 10-27-2022 09-30-2022 10-Q
6 07-28-2022 06-30-2022 10-Q
7 04-28-2022 03-31-2022 10-Q
8 02-09-2022 12-31-2021 10-K
9 10-28-2021 09-30-2021 10-Q
10 07-29-2021 06-30-2021 10-Q
11 04-29-2021 03-31-2021 10-Q
12 02-12-2021 12-31-2020 10-K
13 10-30-2020 09-30-2020 10-Q
14 07-31-2020 06-30-2020 10-Q
15 04-30-2020 03-31-2020 10-Q
16 02-06-2020 12-31-2019 10-K
17 10-30-2019 09-30-2019 10-Q
18 07-16-2019 06-30-2019 10-Q
19 04-26-2019 03-31-2019 10-Q
20 02-07-2019 12-31-2018 10-K
21 10-26-2018 09-30-2018 10-Q
22 07-26-2018 06-30-2018 10-Q
23 04-26-2018 03-31-2018 10-Q
24 02-15-2018 12-31-2017 10-K
25 11-06-2017 09-30-2017 10-Q
26 08-01-2017 06-30-2017 10-Q
27 05-01-2017 03-31-2017 10-Q
28 02-21-2017 12-31-2016 10-K
29 10-27-2016 09-30-2016 10-Q
30 07-26-2016 06-30-2016 10-Q
31 04-29-2016 03-31-2016 10-Q
32 02-19-2016 12-31-2015 10-K
33 10-30-2015 09-30-2015 10-Q
34 07-30-2015 06-30-2015 10-Q
35 05-01-2015 03-31-2015 10-Q
36 02-27-2015 12-31-2014 10-K
37 11-07-2014 09-30-2014 10-Q
38 08-08-2014 06-30-2014 10-Q
39 05-09-2014 03-31-2014 10-Q
40 02-28-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

outdoing-cancer-requires-pharma-to-go-beyond-merely-revolutionizing-existing-treatment
Outdoing Cancer Requires Pharma To Go Beyo...
02/22/2024 17:21:55

Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its...

how-to-earn-500-a-month-from-pfizer-stock
How To Earn $500 A Month From Pfizer Stock
01/02/2024 12:59:52

Pfizer Inc. (NYSE: PFE) shares closed almost flat on Friday, but lost around 44% during 2023.

upward-trajectory-for-biotechpharma-ma-sector-trends-towards-pre-pandemic-levels-forecasts-positive-for-2024
Upward Trajectory For Biotech/Pharma M&A: ...
12/29/2023 12:04:52

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 bill...

Core News & Articles
FDA Approves Expanded Indication For KEYTR...
12/16/2023 23:38:35

Approval is based on results from the Phase 3 KEYNOTE-A39 trial, which demonstrated a superior overall survival benefit with KE...

pfizers-2030-vision-bolstered-by-seagen-deal-analyst-cuts-price-target-amid-conservative-2024-forecast
Pfizer's 2030 Vision Bolstered By Seagen D...
12/14/2023 18:34:24

Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on Pfizer, Inc. (NYSE: PFE), 

Core News & Articles
Pfizer Says It Completed Acquisition of Se...
12/14/2023 12:42:42

looking-into-seagens-recent-short-interest
Looking Into Seagen's Recent Short Interest
12/13/2023 20:30:35

pfizers-dividend-yield-is-57-plus-humana-and-shake-shack-on-cnbcs-final-trades
Pfizer's Dividend Yield Is 5.7%, Plus Huma...
12/13/2023 13:21:58

On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Shake Shack Inc (NYSE: SHAK)

why-is-us-pharma-giant-pfizer-stock-trading-lower-today
Why Is US Pharma Giant Pfizer Stock Tradin...
12/13/2023 12:50:12

Pfizer Inc (NYSE: PFE) provided its full-year 2024 guidance, which includes the expected financial impact from the Seagen Inc (...

pfizer-clears-required-regulatory-hurdles-to-complete-43b-seagen-acquisition
Pfizer Clears Required Regulatory Hurdles ...
12/12/2023 18:03:58

Pfizer Inc (NYSE: PFE) 

bristol-myers-squibbs-mega-84b-oncology-bet---secures-exclusive-license-with-systimmune
Bristol Myers Squibb's Mega $8.4B Oncology...
12/12/2023 14:00:05

SystImmune and Bristol Myers Squibb & Co (NYSE: BMY) 

what-the-options-market-tells-us-about-seagen
What the Options Market Tells Us About Seagen
12/11/2023 19:01:13

seagens-adcetris-plus-novel-immunotherapy-combination-delivers-100-progression-free-survival-at-12-months-in-phase-2-trial-of-patients-with-early-stage-classical-hodgkin-lymphoma
Seagen's ADCETRIS® Plus Novel Immunotherap...
12/11/2023 07:14:08

– 88% of patients with advanced stage classical Hodgkin Lymphoma in trial remained progression free at 24 months – – Investiga...

100-invested-in-seagen-20-years-ago-would-be-worth-this-much-today
$100 Invested In Seagen 20 Years Ago Would...
12/07/2023 17:00:34

tukysa-in-combination-with-antibody-drug-conjugate-ado-trastuzumab-emtansine-improves-progression-free-survival-in-patients-with-previously-treated-her2-positive-metastatic-breast-cancer
TUKYSA In Combination With Antibody-Drug C...
12/06/2023 13:19:51

-- Results of Phase 3 HER2CLIMB-02 trial featured in an oral presentation and official press program at the 2023 San Antonio Br...

Core News & Articles
Seagen Says FDA Grants Priority Review For...
11/30/2023 22:03:45

if-you-invested-1000-in-this-stock-5-years-ago-you-would-have-3600-today
If You Invested $1000 In This Stock 5 Year...
11/20/2023 21:30:17

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
11/10/2023 17:35:20

this-is-the-only-solar-stock-jim-cramer-is-recommending-because-its-a-pure-play
This Is The 'Only Solar Stock' Jim Cramer ...
11/06/2023 14:37:08

On CNBC’s "Mad Money Lightning Round," Jim Cramer said DocuSign, Inc.

heres-how-much-you-would-have-made-owning-seagen-stock-in-the-last-15-years
Here's How Much You Would Have Made Owning...
11/03/2023 17:30:22

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION